Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00006246
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : October 7, 2009
National Cancer Institute (NCI)
Information provided by:
Pediatric Brain Tumor Consortium